Niclosamide induces miR-148a to inhibit PXR and sensitize colon cancer stem cells to chemotherapy-Reference-Cited by-同舟云学术

Niclosamide induces miR-148a to inhibit PXR and sensitize colon cancer stem cells to chemotherapy

Published:2022-04 Issue:4 Volume:17 Page:835-848
ISSN:2213-6711
Container-title:Stem Cell Reports
language:en
Short-container-title:Stem Cell Reports

Author:

Bansard Lucile,Bouvet Océane,Moutin Elisa,Le Gall Gaétan,Giammona Alessandro,Pothin Elodie,Bacou Marion,Hassen-Khodja Cédric,Bordignon Benoit,Bourgaux Jean François,Prudhomme Michel,Hollande Frédéric,Pannequin Julie,Pascussi Jean Marc,Planque Chris

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,Genetics,Biochemistry

Reference49 articles.

1. Cancer stem cells: targeting the roots of cancer, seeds of metastasis, and sources of therapy resistance;Adorno-Cruz;Cancer Res.,2015

2. The biology and toxicology of molluscicides, Bayluscide;Andrews;Pharmacol. Ther.,1982

3. Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer;Arend;Oncotarget,2016

4. Phenotypic and microRNA transcriptomic profiling of the MDA-MB-231 spheroid-enriched CSCs with comparison of MCF-7 microRNA profiling dataset;Boo;PeerJ,2017

5. Phase II trial to investigate the safety and efficacy of orally applied niclosamide in patients with metachronous or sychronous metastases of a colorectal cancer progressing after therapy: the NIKOLO trial;Burock;BMC Cancer,2018

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of STAT3/Fanconi anemia axis by Nifuroxazide is synthetic lethal with PARP inhibitor and selectively targets breast cancer stem cells;2024-08-28

2. Unlocking the Potential: FKK6 as a Microbial Mimicry-Based Therapy for Chronic Inflammation-Associated Colorectal Cancer in a Murine Model;2024-07-30

3. A potent agonist-based PROTAC targeting Pregnane X Receptor that delays colon cancer relapse;2024-06-22

4. Neuroprotective effects of niclosamide on disease progression via inflammatory pathways modulation in SOD1-G93A and FUS-associated amyotrophic lateral sclerosis models;Neurotherapeutics;2024-04

5. Dynamic interplay of nuclear receptors in tumor cell plasticity and drug resistance: Shifting gears in malignant transformations and applications in cancer therapeutics;Cancer and Metastasis Reviews;2024-03